Publications
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
The contribution of the gut microbiota to the emergence of castration-resistant prostate cancer (CRPC) has not yet been addressed.
Microbiome-based therapeutics
Symbiotic microorganisms inhabiting the gastrointestinal tract promote health by decreasing susceptibility to infection and enhancing resistance to a range of diseases.
Fermented foods show potential in increasing gut microbial diversity and modulating immune responses
A new study, carried out by researchers at Stanford University, shows that fermented-food diet may increase microbiome diversity and decrease markers of inflammation.
Study to Evaluate the Response to Supplementation With Postbiotics in Patients With Macular Degeneration (REVERS)
A pilot study to establish the efficacy and safety of supplementation with postbiotics in patients with macular degeneration.
Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206
The present study aims to demonstrate that IGEN-0206 improves the quality of life and nutritional status of patients with non-small cell lung cancer.
Adding single type of bacteria to gut microbiome boosted anti-tumor immunity in mice Peer-Reviewed Publication
A bacterium common in the mouse gut microbiome can charge up the immune system to fight cancer cells in the colon.
New link between diet, intestinal stem cells and disease discovered
Using a mouse model, the researchers investigated the effects of a high-sugar and high-fat diet and compared it with a control group.
Cleveland Clinic study links gut microbiome and aggressive prostate cancer
Cleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, suggesting dietary interventions may help reduce risk.
Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis
The study shows that Enterococcus faecalis is abundant in the microbiota of patients with hepatitis C virus-related chronic liver disease.
